NCI Data Jamboree (Project Abstract Submission): Submission #63
Submission information
Submission Number: 63
Submission ID: 189204
Submission UUID: 4fd1609c-23fa-4a00-9667-2f0c7120520e
Submission URI: /nci/datajamboree/abstractsubmission
Submission Update: /nci/datajamboree/abstractsubmission?token=u7F9UFrwy93mq3dP4zAAKkotRM5qTz-HNZeytgJ05mk
Created: Mon, 07/27/2026 - 23:11
Completed: Mon, 07/27/2026 - 23:11
Changed: Mon, 07/27/2026 - 23:11
Remote IP address: 10.208.24.192
Submitted by: Anonymous
Language: English
Is draft: No
Webform: NCI Data Jamboree (Abstracts)
Submitted to: NCI Data Jamboree (Project Abstract Submission)
| First Name | Avani |
|---|---|
| Middle Initial | |
| Last Name | Patel |
| Degree(s) | N.A. |
| Position/Title/Career Status | |
| Organization | Animal Genome Institute |
| Organization Address | Palmyra |
| info@animalgenomeinstitute.org | |
| List of Additional Authors |
|
| Abstract Category | Employing statistical, computational, and informatics tools, algorithms, and methods to integrate or analyze data |
| Abstract Keywords | |
| Abstract Title | Cross-Species Signature Scoring and Risk Assessment Modeling for Human and Canine Osteosarcoma |
| Abstract | Osteosarcoma is a genetically complex malignancy. While human and canine osteosarcomas share significant molecular similarities, integrating datasets across species and sequencing platforms remains a technical challenge. Overcoming these hurdles is crucial for identifying conserved oncological targets and improving the AI-readiness of comparative genomic data for the broader research community. We aim to develop and validate a robust computational framework for cross-species data integration, specifically focusing on continuous signature scoring models for human and canine osteosarcoma. By utilizing publicly available human osteosarcoma datasets (such as TARGET-OS) and public canine cohorts (such as NCI's DOG² cohort), we will employ expression data scaling techniques, cross-platform normalization, and continuous signature scoring algorithms to harmonize the disparate matrices. Ultimately, we aim to leverage these validated models to develop a cross-species risk assessment application to support clinical decision-making. |